Morgan Stanley Assumes Baxter International (BAX) at Equalweight, 'Modestly infusiastic'

Morgan Stanley analyst Patrick Wood assumes coverage on Baxter International (NYSE: BAX) with a Equalweight rating and a price target of $45.00.

The analyst comments "While our work suggests a small net positive skew on BAX earnings revisions vs. Street, it's not quite enough to get us positive at this point given leverage (>3x net debt / EBITDA) and tougher end markets. Assume coverage at Equal-weight with a PT of $45."

For an analyst ratings summary and ratings history on Baxter International click here. For more ratings news on Baxter International click here.

Shares of Baxter International closed at $41.29 yesterday.

You May Also Be Interested In

• H.C. Wainwright Assumes MiNK Therapeutics (INKT) at Buy
• Kraft Heinz Company (KHC) PT Raised to $24 at Jefferies
• ArcBest Corp (ARCB) PT Lowered to $146 at TD Cowen